Furthermore, preliminary studies have shown that C1QBP targeted therapy, such as using anti-C1QBP antibodies in breast cancer [20], and C1QBP inhibitor in glioma [21] have a potential therapeutic value. Here, C1QBP is linked to breast carcinoma.